British scientists will conduct a study to determine the effectiveness of aspirin as a coronavirus treatment, according to reports.
According to the trial’s website, the RESTORE trial will attempt to evaluate a wide range of treatment options, including low-dose dexamethasone, azithromycin, nursing plasma and aspirin, among others.
Focusing on aspirin will determine whether aspirin can help reduce the risk of blood clots in people with COVID-19, Reuters reported.
Patients infected with the virus are at greater risk of blood clots due to overreacting platelets and aspirin being an anti-platelet aggregation.
RAVE UK ORGANIZATION HAS STRONGED $ 13G FOR VIOLATION OF CORONAVIRUS RESTRICTIONS
At least 2,000 patients are expected to participate in one of the UK’s largest trials. Each participant will receive 150 mg. daily dose of aspirin. These patients will be compared to another 2,000 others receiving only the standard treatment.
The study mainly looked at patient mortality after 28 days while simultaneously assessing hospital stay and need for ventilation, Politico reported.
EUROPEAN CEREMONY OF BIDDING WINS BY FIRE AND CHEMICAL
“Aspirin is widely used to prevent blood clots in many other conditions, including heart attack, stroke and pre-eclampsia in pregnant women,” said Professor Martin Landray, co-investigator of the trial. know.
“But including patients in a randomized trial like Recovery is the only way to assess whether there are clear benefits to patients with COVID-19 and whether those benefits outweigh any effects. any potential side effects, such as risk of bleeding or not. ”
Other treatments being tested in the Recovery trial include antibody-rich plasma collected from recovered COVID-19 patients and Regeneron’s antibody cocktail used to treat symptoms. COVID-19 by Donald Trump.
CLICK HERE TO VIEW FOX NEWS APP
The results of these tests will likely take months to confirm, but if aspirin does work, it will be an inexpensive option to help correct symptoms.